Drug recall D-0701-2026

Class II Ongoing reported Jul 29, 2026

Product

Levothyroxine Sodium Tablets, USP, 50 mcg (0.050 mg), 100 Tablets (10 x 10 unit dose blisters) per carton, Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN 46268 USA. NDC: 0904-6950-61

Reason for recall

Subpotent Drug

Lots and codes

Lot #: N02200, Exp. Date 10/2026

Recall details

Recalling firm
Major Pharmaceuticals, Dublin, OH
Quantity
N/A
Distribution
Nationwide in the USA.
Type
Voluntary: Firm initiated
Recall initiated
July 13, 2026

Related products